Skip to main content

Table 1 Baseline characteristics of RA patients

From: Baseline CXCL10 and CXCL13 levels are predictive biomarkers for tumor necrosis factor inhibitor therapy in patients with moderate to severe rheumatoid arthritis: a pilot, prospective study

 

Responders (n = 16)

Nonresponders (n = 13)

p value

Age (years)

51.6 ± 12.7

50.7 ± 8.1

0.80a

Gender (female %)

69 (11/16)

77 (10/13)

0.70b

Duration (years)

6.5 ± 4.9

7.4 ± 7.5

0.66a

RF or anti-CCP positive (%)

75 (12/16)

54 (7/13)

0.27b

DAS28 ESR

6.2 ± 1.1

6.7 ± 0.6

0.15a

ESR (mm)

37 ± 31

30 ± 22

0.79a

  1. Values are presented as mean with standard deviation. P values were determined by Wilcoxon ranked sum testa and by Fisher’s exact testb
  2. RF rheumatoid factor, anti-CCP anti-cyclic citrullinated peptide​, DAS28 ESR disease activity score in 28 joints based on erythrocyte sedimentation rate, ESR erythrocyte sedimentation rate
Back to article page

Arthritis Research & Therapy

ISSN: 1478-6362

Contact us